業績紹介

業績紹介

2019年

[原著(英文)]
Watanabe E, KiyonoK, Harada M, Ozaki Y.
Seasonal Variability in The Implantations of Cardiovascular Electronic Devices.
Cardiol Cardiovasc Med 2019; 3(4): 131-139.
Kawai H, Watanabe E, Ohno S, Horie M, Ozaki Y.
Cardiac Arrest Associated with Both an Anomalous Left Coronary Artery and KCNE1 Polymorphism.
Int Heart J 2019; 60(4): 1003-1005.
Frigoli E, Smits P, Vranckx P, Ozaki Y, Tijssen J, Jüni P, Morice MC, Onuma Y, Windecker S, Frenk A, Spaulding C, Chevalier B, Barbato E, Tonino P, Hildick-Smith D, Roffi M, Kornowski R, Schultz C, Lesiak M, Iñiguez A, Colombo A, Alasnag M, Mullasari A, James S, Stankovic G, Ong PJL, Rodriguez AE, Mahfoud F, Bartunek J, Moschovitis A, Laanmets P, Leonardi S, Heg D, Sunnåker M, Valgimigli M.
Design and rationale of the Management of High Bleeding Risk Patients Post Bioresorbable Polymer Coated Stent Implantation With an Abbreviated Versus Standard DAPT Regimen (MASTER DAPT) Study.
Am Heart J. 2019 Mar; 209:97-105. doi: 10.1016/j.ahj.2018.10.009. Epub 2018 Nov 22.
Kawai H, Ohta M, Motoyama S, Hashimoto Y, Takahashi H, Muramatsu T, Sarai M, Narula J, Ozaki Y.
Computed Tomographic Angiography-Verified Myocardial Bridge and Invasive Angiography-Verified Left Anterior Descending Coronary Artery Vasospasm.
JACC Cardiovasc Interv. 2019 Sep 14. pii: S1936-8798(19)31771-6. doi: 10.1016/j.jcin.2019.08.023. [Epub ahead of print]
Kawai H, Watanabe E, Ohno S, Horie M, Ozaki Y.
Cardiac Arrest Associated with Both an Anomalous Left Coronary Artery and KCNE1 Polymorphism.
Int Heart J. 2019 Jul 27;60(4):1003-1005. doi: 10.1536/ihj.18-581. Epub 2019 Jul 12.
Wendt H, Abry P, Kiyono K, Hayano J, Watanabe E, Yamamoto Y.
Wavelet p-leader non- Gaussian multiscale expansions for heart rate variability analysis in congestive heart failure patients.
IEEE Trans Biomed Eng. 2019; 66(1): 80-8.
Amino M, Yoshioka K, Ichikawa T, Watanabe E, Kiyono K, Nakamura M, Sakama S, Ayabe K, Fujii T, Hashida T, Kanda S, Tanabe T and Ikari Y.
The presence of late potentials after percutaneous coronary intervention for the treatment acute coronary syndrome as a predictor for future significant cardiac events resulting in re-hospitalization.
J Electrocardiol. 2019; 53:71-8.
Kawai M, Harada M, Motoike Y, Koshikawa M, Ichikawa T, Watanabe E, Ozaki Y.
Impact of serum albumin levels on supratherapeutic PT-INR control and bleeding risk in atrial fibrillation patients on warfarin: A prospective cohort study.
Int J Cardiol Heart Vasc. 2019; 22: 111-6.
Yamamoto M, Okajima K, Shimane A, Ozawa T, Morishima I, Asai T, Takagi M, Kasai A, Fujii E, Kiyono K, Watanabe E, Ozaki Y.
A decision Tree-Based Survival Analysis of Patients with a History of Inappropriate Implantable Cardioverter-Defibrillator Therapy.
Int Heart J. 2019; 60(2): 318-26.
Okishige K, Yamauchi Y, Hanaki Y, Inoue K, Tanaka N, Yamaji H, Murakami T, Manita M, Tabata K, Ooie T, Tatsukawa Y, Sakai H, Yamaki M, Murakami M, Takada T, Osaka Y, Ono Y, Handa K, Sugiyama K, Yoshizawa T, Fukaya H, Tashiro H, Takase S, Harada M, Watanabe E, Yamane T, Yamashita S, Aonuma K.
Clinical experience of idarucizumab use in cases of cardiac tamponade under uninterrupted anticoagulation of dabigatran during catheter ablation of atrial fibrillation.
J Thromb Thrombolysis. 2019 Apr 6. doi: 10.1007/s11239-019-01835-8. [Epub ahead of print]